Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Retained Earnings (2023 - 2025)

Cannabis Bioscience International Holdings' Retained Earnings history spans 3 years, with the latest figure at -$6.1 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 10.79% year-over-year to -$6.1 million; the TTM value through Nov 2025 reached -$6.1 million, down 10.79%, while the annual FY2025 figure was -$5.9 million, 10.29% down from the prior year.
  • Retained Earnings for Q4 2025 was -$6.1 million at Cannabis Bioscience International Holdings, down from -$6.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$4.7 million in Q2 2023 and bottomed at -$6.1 million in Q4 2025.
  • The 3-year median for Retained Earnings is -$5.5 million (2024), against an average of -$5.5 million.
  • The largest annual shift saw Retained Earnings decreased 13.91% in 2024 before it decreased 9.1% in 2025.
  • A 3-year view of Retained Earnings shows it stood at -$5.0 million in 2023, then dropped by 10.04% to -$5.5 million in 2024, then fell by 10.79% to -$6.1 million in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Retained Earnings are -$6.1 million (Q4 2025), -$6.0 million (Q3 2025), and -$5.9 million (Q2 2025).